Come up with a name for your new list and we'll add to it:
Selexys Pharmaceuticals raised a round of funding on November 01, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Selexys Pharmaceuticals is focused on development of therapeutics for the treatment of inflammation, thrombosis, and metastasis across a broad range of severe diseases. Selexys is also developing an a…